Randox

As the largest healthcare diagnostics company from the UK and Ireland, Randox undertakes research, development, manufacture and distribution of innovative laboratory tests and equipment. In 2019 Randox, manufactured over 4 billion tests, and operated in 145 countries. With over 2,000 staff, including over 450 research scientists and engineers, key facilities are located in Co Antrim and Co Donegal.

Randox focuses on the provision of comprehensive, accurate and timely testing in order to identify risk to health, improve clinical diagnoses and promote preventative healthcare; aiming to achieve better healthcare outcomes whilst reducing the burden on clinical services.

In that regard Randox’s innovative Biochip Technology allows many tests to be run simultaneously, greatly improving the diagnostic power available to clinicians. These technologies enable Randox Health Clinics in Liverpool, London and Northern Ireland, to provide public access to advanced health screening involving of hundreds of diagnostic tests. Such packages provide an extraordinary insight into a person’s current and future health.

In early 2020 Randox recognised the threat from COVID-19 and, based on almost 40 years of diagnostic experience, quickly developed a test to accurately identify the virus. Testing at scale commenced within weeks to support both the UK’s National Testing Programme and private clients. Through the enormous effort and commitment of their staff Randox is currently operating at a capacity of 100,000 COVID-19 samples per day, making it the most productive laboratory in the UK and Ireland and amongst the very largest in Europe. Further expansion is planned, and testing is provided for both government and private clients.

Randox is clear that better diagnostics are unquestionably critical to future improvements within healthcare, and is committed to remaining at the forefront of that field.